Page last updated: 2024-08-21

benzoxazoles and Dysembryoma

benzoxazoles has been researched along with Dysembryoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allen, SJ; Eberhart, CG; Orr, BA; Price, A; Raabe, EH; Rubens, JA; Wang, SZ; Weingart, MF	1

Other Studies

1 other study(ies) available for benzoxazoles and Dysembryoma

Article	Year
The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity. Neuro-oncology, 2017, Oct-01, Volume: 19, Issue:10 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoxazoles; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Humans; Mice; Protein Kinase Inhibitors; Pyrimidines; Rhabdoid Tumor; Teratoma; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2017

Article

Year

The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity.

Neuro-oncology, 2017, Oct-01, Volume: 19, Issue:10

Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoxazoles; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Humans; Mice; Protein Kinase Inhibitors; Pyrimidines; Rhabdoid Tumor; Teratoma; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2017